Industry: Healthtech
Privacy governance for sensitive health data operations
Coordinate legal, compliance, and security teams with HIPAA-aware workflows and robust evidence controls.
Primary pains
- Manual data subject request handling
- Complex access controls across clinical systems
- Audit preparation consumes limited team bandwidth
Use cases
- Consent versioning and revocation controls
- ROPA for clinical and operational processing
- Findings management linked to remediation evidence
Suggested workflows
Consent tracking + DSAR operations + HIPAA control checks + monthly risk register governance.
Compliance mapping
GDPR/CCPA/UAE mapping for international operations with HIPAA control pack support.
Expected outcomes
Improve compliance readiness, cut audit prep time, and strengthen data access governance.
Frequently asked questions
HIPAA is a US sector-specific law covering protected health information held by covered entities and their business associates. GDPR is an EU cross-sector law covering all personal data, with health data treated as a special category requiring an additional condition for processing. A healthtech company operating in both markets must satisfy both.
A BAA is the contract HIPAA requires between a covered entity and any vendor that handles protected health information on its behalf. Without one in place, the vendor cannot lawfully process PHI — which makes it a gating item in every healthcare sales cycle.
Because misuse causes disproportionate harm — to employment, insurance, and personal safety — and it cannot be undone. Under GDPR that means processing it requires both a lawful basis and a separate Article 9 condition, and it very commonly triggers a DPIA.
Health records frequently contain third-party data — a clinician's notes, a family member's history — that must be redacted before disclosure. There may also be a clinical-harm exemption. Both require judgement, which means a healthtech DSAR process cannot be fully automated end to end.